Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 77 Total
HUGE - FSD Pharma Inc - Stock Price Chart
TickerHUGE [NASD]
CompanyFSD Pharma Inc
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap14.96MEPS (ttm)-0.47
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y31.10%
P/S-EPS next 5Y-
P/B1.10EPS Q/Q73.81%
Dividend-Sales Q/Q-
Insider Own16.97%Inst Own1.21%
Insider Trans0.00%Inst Trans-
Short Float1.11%EarningsNov 15/b
Analyst Recom1.00Target Price5.97
Avg Volume210.32K52W Range0.35 - 1.68
Apr-30-24 08:33AM FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication (ACCESSWIRE) -6.96%
Apr-25-24 07:47AM FSD Pharma Provides Update from Celly Nu's Partnership with Six+One for unbuzzd(TM) (ACCESSWIRE)
Apr-22-24 08:00AM FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) (ACCESSWIRE)
Apr-17-24 08:00AM FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products (ACCESSWIRE) -7.80%
Apr-15-24 08:00AM FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption (ACCESSWIRE) -12.40%
Apr-07-24 10:55PM FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (Newsfile)
Apr-01-24 10:00PM FSD Pharma Announces Filing of Year-End 2023 Results (ACCESSWIRE)
Mar-27-24 08:00AM FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults (ACCESSWIRE)
Mar-11-24 08:00AM FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM) (ACCESSWIRE)
Mar-05-24 08:00AM FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum (ACCESSWIRE)
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
RELI - Reliance Global Group Inc - Stock Price Chart
TickerRELI [NASD]
CompanyReliance Global Group Inc
CountryUSA
IndustryInsurance Brokers
Market Cap1.43MEPS (ttm)-5.52
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.10EPS next 5Y-
P/B0.17EPS Q/Q75.38%
Dividend-Sales Q/Q-20.16%
Insider Own19.16%Inst Own5.85%
Insider Trans0.02%Inst Trans-92.28%
Short Float2.11%EarningsApr 05/b
Analyst Recom1.00Target Price7.00
Avg Volume1.07M52W Range0.25 - 5.20
Apr-23-24 07:30AM Reliance Global Group Inc.: Invitation to EF Hutton Annual Global Conference (Newsfile)
Apr-04-24 01:52PM RELI Stock Earnings: Reliance Global Group Reported Results for Q4 2023 (InvestorPlace) +43.24%
09:30AM New to The Street TV Announces its Next Two Shows Broadcastings with Five Business Guest Interviews, Episode 566 Airs on Bloomberg TV as A Sponsored Programming Tonight, Thursday, April 4, 2024, at 9:30 PM PT, and Episode 567 Airs on The FOX Business Network, Monday, April 8, 2024, at 10:30 PM PT (GlobeNewswire)
08:00AM Reliance Global Group's Revenue Grows by 17% and 40% in 2023 Compared to 2022 and 2021, respectively (GlobeNewswire)
Apr-03-24 08:30AM Reliance Global Group Schedules Fourth Quarter 2023 Financial Results and Business Update Conference Call (GlobeNewswire)
Jan-30-24 08:30AM RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform (GlobeNewswire) -7.88%
Jan-19-24 09:30AM New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT (GlobeNewswire) +7.58%
Dec-19-23 08:30AM Reliance Global Group Provides Year-End Update on RELI Exchange (GlobeNewswire) -5.75%
Dec-08-23 09:46AM New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT (GlobeNewswire)
Dec-07-23 09:20AM New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT (GlobeNewswire)
Reliance Global Group, Inc. is a diversified company, which engages in the business of insurance market and other relates sectors. It focuses on acquisition strategy, wholesale, and retail insurance agencies. The company was founded on August 2, 2013 and is headquartered in Lakewood, NJ.
APDN - Applied Dna Sciences Inc - Stock Price Chart
TickerAPDN [NASD]
CompanyApplied Dna Sciences Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap3.23MEPS (ttm)-10.99
P/E-EPS this Y14.47%
Forward P/E-EPS next Y18.46%
PEG-EPS past 5Y45.52%
P/S0.36EPS next 5Y-
P/B0.61EPS Q/Q70.94%
Dividend-Sales Q/Q-83.07%
Insider Own12.32%Inst Own16.65%
Insider Trans0.00%Inst Trans-
Short Float1.78%EarningsFeb 08/a
Analyst Recom1.00Target Price45.00
Avg Volume12.98K52W Range3.60 - 37.20
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
SHMD - SCHMID Group N.V. - Stock Price Chart
TickerSHMD [NASD]
CompanySCHMID Group N.V.
CountryCayman Islands
IndustryElectronic Components
Market Cap40.88MEPS (ttm)-0.12
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.15EPS Q/Q-100.11%
Dividend-Sales Q/Q-
Insider Own55.91%Inst Own47.45%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume63.92K52W Range4.01 - 11.50
Pegasus Digital Mobility Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on March 30, 2021 and is headquartered in George Town, Cayman Islands.
INFU - InfuSystem Holdings Inc - Stock Price Chart
TickerINFU [AMEX, RUT]
CompanyInfuSystem Holdings Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap159.88MEPS (ttm)0.04
P/E189.90EPS this Y341.67%
Forward P/E18.57EPS next Y129.24%
PEG9.49EPS past 5Y-
P/S1.27EPS next 5Y20.00%
P/B3.05EPS Q/Q-34.00%
Dividend-Sales Q/Q10.20%
Insider Own12.24%Inst Own73.11%
Insider Trans0.00%Inst Trans0.37%
Short Float1.15%EarningsMay 09/b
Analyst Recom1.00Target Price14.83
Avg Volume46.09K52W Range7.41 - 11.44
InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Patient Services and Device Solutions segments. The Patient Services segment involves the durable medical equipment, clinic-to-home health care, logistics and billing, and oncology business. The Device Solutions segment includes the sale or rent of new and pre-owned pole-mounted and ambulatory infusion pumps, treatment-related consumables, biomedical recertification, maintenance and repair services for oncology practices. The company was founded by Steven E. Watkins in August 2005 and headquartered in Rochester Hills, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lachance CarriePresident and COOMar 01 '24Option Exercise0.0050,0000193,745Mar 05 08:00 PM
Chupa AddamExecutive VP and CIOFeb 09 '24Option Exercise0.003,000022,393Feb 13 08:51 PM
Malhotra R. RimmyDirectorSep 06 '23Sale10.0912,500126,07345,000Sep 08 06:38 PM
Malhotra R. RimmyDirectorSep 05 '23Sale10.195,00050,97257,500Sep 05 06:16 PM
Malhotra R. RimmyDirectorSep 01 '23Sale10.2412,500128,03662,500Sep 05 06:16 PM
BRID - Bridgford Foods Corp. - Stock Price Chart
TickerBRID [NASD]
CompanyBridgford Foods Corp.
CountryUSA
IndustryPackaged Foods
Market Cap90.98MEPS (ttm)0.42
P/E24.08EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-11.82%
P/S0.37EPS next 5Y-
P/B0.70EPS Q/Q32.52%
Dividend-Sales Q/Q-11.00%
Insider Own81.64%Inst Own4.71%
Insider Trans0.02%Inst Trans1.87%
Short Float0.23%Earnings-
Analyst Recom-Target Price-
Avg Volume1.89K52W Range10.03 - 13.41
Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silva Juan LuisV.P. Plant SuperintendentApr 01 '24Buy11.301001,130208Apr 01 05:22 PM
Bridgford Allan Jr.ConsultantMar 20 '24Buy11.391517143,000Mar 28 02:39 PM
Bridgford Richard EugeneV.P. Ind. Relations & SafetyMar 18 '24Buy10.621952,0712,295Mar 18 06:16 PM
Bridgford Allan Jr.ConsultantMar 18 '24Buy10.751341,44042,965Mar 18 06:15 PM
Bridgford Allan Jr.ConsultantMar 15 '24Buy10.778288342,831Mar 18 06:15 PM
NCL - Northann Corp. - Stock Price Chart
TickerNCL [AMEX]
CompanyNorthann Corp.
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap8.87MEPS (ttm)-0.34
P/E-EPS this Y-970.90%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.63EPS next 5Y-
P/B13.83EPS Q/Q-679.80%
Dividend-Sales Q/Q275.00%
Insider Own67.49%Inst Own0.34%
Insider Trans0.00%Inst Trans-
Short Float0.74%Earnings-
Analyst Recom-Target Price-
Avg Volume171.43K52W Range0.41 - 22.40
Northann Corp. engages in the manufacture, wholesale, and retail of the 3D printed vinyl flooring panels and other decorative panels in North America, Europe, and internationally. The company offers its products under the Benchwick brand name. Northann Corp. was founded in 2013 and is based in Elk Grove, California.
12345678